Skip to main content

Biotricity to Host Fiscal 2023 Second Quarter Financial Results on November 14th at 4:30 PM ET

REDWOOD CITY, CA / ACCESSWIRE / November 1, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, today announced it will host a conference call on Monday, November 14, 2022 at 4:30 p.m. ET to discuss its financial results for the fiscal 2023 second quarter and provide a business update.

Financial Results Conference Call
Additional details are available under the Investor Relations section of the Company's website:


Biotricity Fiscal 2023 Second Quarter Financial Results Conference Call


Monday, November 14, 2022


4:30 p.m. Eastern Time

Live Call:

1-866-575-6539 (U.S. Toll-Free) or 1-646-828-8193 (International)


For interested individuals unable to join the conference call, a dial-in replay of the call will be available until November 28, 2022 and can be accessed by dialing +1-844-512-2921 (U.S. Toll Free) or +1-412-317-6671 (International) and entering replay pin number: 8592059.

About Biotricity:
Biotricity is reforming the healthcare market by bridging the gap in remote monitoring and chronic care management. Doctors and patients trust Biotricity's unparalleled standard for preventive & personal care, including diagnostic and post-diagnostic solutions for chronic conditions. The company develops comprehensive remote health monitoring solutions for the medical and consumer markets. To learn more, visit

Investor Relations:
KCSA Strategic Communications
Valter Pinto or Jack Perkins
(212) 896-1254

SOURCE: Biotricity, Inc.

View source version on

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.